Hyperlipidaemias as a side-effect of drug therapy
- At: 2011 FIP Congress in Hyderabad (India)
- Type: Poster
- By: SKRBO, Selma (Faculty of Pharmacy, Sarajevo, Bosnia and Herzegovina)
- Co-author(s): Skrbo, Armin (Faculty of Pharmacy, Sarajevo, Bosnia and Herzegovina)
Sehovic, Amra (Samed d.o.o., Sarajevo, Bosnia and Herzegovina)
BACKGROUND: Epidemiologic studies have defined lipid disorders as highly significant independent risk factors for coronary heart disease, along with diabetes mellitus, hypertension and smoking. The causes of secondary hyperlipidaemia are generally well known, but not always diagnosed. A large number of drugs can adversely affect serum lipid and.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.